文献速递肿瘤 PET/CT放射性药物与辐射防护

侵入性医疗干预后FAPI PET摄取模式:一项单中心回顾性分析

FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-05-16

该单中心回顾性分析纳入79例连续接受[68Ga]Ga-FAPI-46 PET/CT的患者,评估侵入性非系统性医疗干预后的FAPI摄取模式。结果显示,无外来植入物的干预后FAPI摄取似乎呈时间依赖性,干预后超过8个月几乎均无摄取;而存在外来植入物时摄取可持续多年。

要点

  • 无外来植入物的干预后,超过8.2个月无FAPI摄取,灵敏度82%、特异度90%、阳性预测值99%、阴性预测值31%。
  • 有外来植入物时无法确定最佳截断时间点。
  • [68Ga]Ga-FAPI-46与[18F]FDG在干预部位的摄取频率无显著差异;较[68Ga]Ga-PSMA-11更频繁且更强烈。

核心结论

  • [68Ga]Ga-FAPI-46在无外来植入物的医疗/侵入性干预后的摄取似乎呈时间依赖性,干预后超过8个月几乎均无摄取,但存在外来植入物时摄取可持续多年。

研究设计与样本

  • 单中心回顾性分析纳入79例连续接受[68Ga]Ga-FAPI-46 PET/CT的患者,其中60例受试者的163次医疗/侵入性干预纳入分析。

主要发现

  • 163次干预中,43/163(26%)涉及外来植入物。
  • FAPI摄取见于24/163(15%)的干预,平均SUVmax为3.2(轻度),范围1.5-5.1。
  • 干预后至FAPI-PET的中位时间间隔为47.5个月;有FAPI摄取时中位间隔为9.5个月,短于无摄取时的60.1个月(p=0.001)。
  • 无外来植入物时,干预后无FAPI摄取的时间截断值为8.2个月,灵敏度、特异度、阳性预测值和阴性预测值分别为82%、90%、99%和31%。
  • 考虑有外来植入物的干预时,无法确定最佳截断点。

关键数值与推荐

  • FAPI摄取视觉判读为阳性若高于周围本底,定量采用SUVmax。
  • 无外来植入物时,干预后8.2个月为无FAPI摄取的时间截断值,灵敏度82%、特异度90%、阳性预测值99%、阴性预测值31%。

临床怎么用

  • 解读[68Ga]Ga-FAPI-46 PET/CT时,需结合患者近期医疗/侵入性干预史及外来植入物情况,干预后8个月内可能出现FAPI摄取。
  • 无外来植入物时,干预后超过8个月FAPI摄取几乎均不存在。
  • 有外来植入物时,FAPI摄取可持续多年,无法确定最佳时间截断点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fibroblast activation protein (FAP)-inhibitor (FAPI)-PET tracers allow imaging of the FAP-expressing cancer associated fibroblasts (CAF) and also the normal activated fibroblasts (NAF) involved in inflammation/fibrosis that may be present after invasive medical interventions. We evaluated [68Ga]Ga-FAPI-46 uptake patterns post-medical/invasive non-systemic interventions. METHODS: This single-center retrospective analysis was conducted in 79 consecutive patients who underwent [68Ga]Ga-FAPI-46 PET/CT. Investigators reviewed prior patient medical/invasive interventions (surgery, endoscopy, biopsy, radiotherapy, foreign body placement (FBP) defined as implanted medical/surgical material present at time of scan) and characterized the anatomically corresponding FAPI uptake intensity both visually (positive if above surrounding background) and quantitatively (SUVmax). Interventions with missing data/images or confounders of [68Ga]Ga-FAPI-46 uptake (partial volume effect, other cause of increased uptake) were excluded. Available correlative FDG, DOTATATE and PSMA PET/CTs were analyzed when available. RESULTS: 163 medical/invasive interventions (mostly surgeries (49%), endoscopies (18%) and non-surgical biopsies (10%)) in 60 subjects were included for analysis. 43/163 (26%) involved FBP. FAPI uptake occurred in 24/163 (15%) of interventions (average SUVmax 3.2 (mild), range 1.5-5.1). The median time-interval post-intervention to FAPI-PET was 47.5 months and was shorter when FAPI uptake was present (median 9.5 months) than when absent (median 60.1 months; p = 0.001). Cut-off time beyond which no FAPI uptake would be present post-intervention without FBP was 8.2 months, with a sensitivity, specificity, positive predictive value and negative predictive value of 82, 90, 99 and 31% respectively. No optimal cutoff point could be determined when considering interventions with FBP. No significant difference was detected between frequency of [68Ga]Ga-FAPI-46 and [18F]FDG uptake in intervention sites. Compared to [68Ga]Ga-PSMA-11, [68Ga]Ga-FAPI-46 revealed more frequent and intense post-interventional tracer uptake. CONCLUSION: [68Ga]Ga-FAPI-46 uptake from medical/invasive interventions without FBP appears to be time dependent, nearly always absent beyond 8 months post-intervention, but frequently present for years with FBP.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Maliha PG, Hotta M, Farolfi A, et al. FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis. Eur J Nucl Med Mol Imaging. 2024. PMID: 38750372. doi:10.1007/s00259-024-06733-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。